Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
- Eli Lilly: 14 events in the last 90 days
- Previous: earlier the same day · Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial
What happened
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Summary assembled by rule from the sources below